Skip to main content
NIH funding notice PAR-20-276

Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)

Closed on January 7, 2023.

Posted
July 22, 2020
Close date
January 7, 2023
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

9 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $4,040,122 in first-year total cost, median $461,852.

Most frequent study sections

  1. Cancer and Hematologic Disorders Study Section[CHD]3
  2. Biodata Management and Analysis Study Section[BDMA]2
  3. Cancer Biomarkers Study Section[CBSS]1
  4. Cancer Genetics Study Section[CG]1
  5. Molecular Cancer Diagnosis and Classification Study Section[MCDC]1

Most frequent institutions

  1. BAYLOR COLLEGE OF MEDICINE1
  2. MAYO CLINIC ROCHESTER1
  3. STANFORD UNIVERSITY1
  4. UNIVERSITY OF CALIFORNIA AT DAVIS1
  5. UNIVERSITY OF CALIFORNIA LOS ANGELES1
Competing awards under PAR-20-276 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2023Polygenic Risk Prediction of Breast Cancer for Women of African Descent2R01CA228198-05A1HUO, DEZHENGUNIVERSITY OF CHICAGO, IL$515,299ZRG1
2023Integrating Epidemiologic and Genomic Data to Elucidate the Genetic Overlap Between Congenital Anomalies and Pediatric Cancer1R01CA284531-01HUFF, CHAD DANIELLUPO, PHILIPUNIVERSITY OF TX MD ANDERSON CAN CTR, TX$483,022CHD
2023Multifactor risk scores with susceptibility gene mutations to enhance risk assessment of pancreatic cancer1R01CA272668-01A1OBERG, ANN LAURAMAYO CLINIC ROCHESTER, MN$468,867CHD
2023An innovative integrated computational framework using gene signatures for patient stratification1R01CA269764-01A1CHENG, CHAOBAYLOR COLLEGE OF MEDICINE, TX$464,640CBSS
2023Her2 status of breast cancer in diverse populations: improving genetic prediction and understanding molecular correlates1R01CA273313-01A1FEJERMAN, LAURAUNIVERSITY OF CALIFORNIA AT DAVIS, CA$461,852CHD
2023Integrating cancer genomics and spatial architecture of tumor infiltrating lymphocytes1R01CA280089-01JI, HANLEE PSTANFORD UNIVERSITY, CA$445,177MCDC
2022Comprehensive identification of germline-somatic interactions1R01CA269919-01ALEXANDROV, LUDMIL BCARTER, HANNAH KATHRYNUNIVERSITY OF CALIFORNIA, SAN DIEGO, CA$458,990CG
2022Exploiting public genomic and transcriptomic data to uncover cancer-RNA editing relationships1R01CA262686-01A1XIAO, XINSHU GRACEUNIVERSITY OF CALIFORNIA LOS ANGELES, CA$390,000BDMA
2021Algorithm-based prevention and reduction of cancer health disparity arising from data inequality1R01CA262296-01CUI, YANUNIVERSITY OF TENNESSEE HEALTH SCI CTR, TN$352,275BDMA

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

PAR-20-276: Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed) | ScienceDex | ConductScience